Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACCELERATING THE PATH TO SCALE FOR INJECTABLE HIV PRE-EXPOSURE PROPHYLAXIS (PrEP) in MALAWI: THE PERSIST TRIAL

NCT07221747 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT07221747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07221747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACCELERATING THE PATH TO SCALE FOR INJECTABLE HIV PRE-EXPOSURE PROPHYLAXIS (PrEP) in MALAWI: THE PERSIST TRIAL
Lead sponsor
Georgetown University
Phase
Not applicable
Overall status
Recruiting
Start date
February 16, 2026
Completion date
November 30, 2026
Enrollment
9,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long-acting injectable cabotegravir for prep, oral pre-exposure prophylaxis (prep)